SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Sridhar, P. Gautret, P. Brouqui, A comprehensive review of the Kumbh Mela: identifying risks for spread of infectious diseases, Clinical Microbiology and Infection, 2015, 21, 2, 128

    CrossRef

  2. 2
    Marco Aurélio Sáfadi, Julie A Bettinger, Gabriela Moreno Maturana, Godwin Enwere, Ray Borrow, Evolving meningococcal immunization strategies, Expert Review of Vaccines, 2015, 14, 4, 505

    CrossRef

  3. 3
    Sabine Dittrich, Sayaphet Rattanavong, Sue J Lee, Phonepasith Panyanivong, Scott B Craig, Suhella M Tulsiani, Stuart D Blacksell, David A B Dance, Audrey Dubot-Pérès, Amphone Sengduangphachanh, Phonelavanh Phoumin, Daniel H Paris, Paul N Newton, Orientia, rickettsia, and leptospira pathogens as causes of CNS infections in Laos: a prospective study, The Lancet Global Health, 2015, 3, 2, e104

    CrossRef

  4. 4
    Sanjay Lalwani, Sharad Agarkhedkar, Nithya Gogtay, Sonali Palkar, Shalaka Agarkhedkar, Urmila Thatte, Hoshang Vakil, Rekha Jonnalagedda, Paola Pedotti, Margaret Hoyle, Chiranjiwi Bhusal, Ashwani Arora, Safety and immunogenicity of an investigational meningococcal ACWY conjugate vaccine (MenACWY-CRM) in healthy Indian subjects aged 2 to 75 years, International Journal of Infectious Diseases, 2015, 38, 36

    CrossRef

  5. 5
    C. E. Frasch, S. V. Kapre, C.-H. Lee, J.-M. Preaud, Technical Development of a New Meningococcal Conjugate Vaccine, Clinical Infectious Diseases, 2015, 61, suppl 5, S404

    CrossRef

  6. 6
    Sangeeta Yadav, M. V. Manglani, D. H. Ashwath Narayan, S. Sharma, H. S. Ravish, Rohit Arora, V. Bosch Castells, S. Arya, P. Oster, Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-DT): A multicenter, open-label, non-randomized, phase III clinical trial, Indian Pediatrics, 2014, 51, 6, 451

    CrossRef

  7. 7
    T. Jacob John, Sunil Gupta, A.J. Chitkara, Ashok Kumar Dutta, Ray Borrow, An overview of meningococcal disease in India: Knowledge gaps and potential solutions, Vaccine, 2013, 31, 25, 2731

    CrossRef

  8. 8
    Nadège Martiny, Isabelle Chiapello, Assessments for the impact of mineral dust on the meningitis incidence in West Africa, Atmospheric Environment, 2013, 70, 245

    CrossRef

  9. 9
    Vipin M. Vashishtha, Ajay Kalra, Anuradha Bose, Panna Choudhury, Vijay N. Yewale, C. P. Bansal, Sailesh G. Gupta, Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2013 and updates on immunization, Indian Pediatrics, 2013, 50, 12, 1095

    CrossRef

  10. 10
    J.D. Caballero, R. López-Vélez, Shock séptico y exantema purpúrico en un viajero, Vacunas, 2013, 14, 1, 49

    CrossRef

  11. 11
    Brian Greenwood, Emiliano Chiarot, Calman A. MacLennan, Miguel O’Ryan, Can we defeat meningococcal disease in low and middle income countries?, Vaccine, 2012, 30, B63

    CrossRef

  12. 12
    Martin C.J. Maiden, Matthias Frosch, Can we, should we, eradicate the meningococcus?, Vaccine, 2012, 30, B52

    CrossRef

  13. 13
    Carl Frasch, Marie-Pierre Preziosi, F. Marc LaForce, Development of a group A meningococcal conjugate vaccine,MenAfriVacTM, Human Vaccines & Immunotherapeutics, 2012, 8, 6, 715

    CrossRef

  14. 14
    Siddhivinayak Hirve, Ashish Bavdekar, Anand Pandit, Sanjay Juvekar, Malini Patil, Marie-Pierre Preziosi, Yuxiao Tang, Elisa Marchetti, Lionel Martellet, Helen Findlow, Cheryl Elie, Varsha Parulekar, Brian Plikaytis, Ray Borrow, George Carlone, Prasad S. Kulkarni, Akshay Goel, Karupothula Suresh, Suresh Beri, Subhash Kapre, Suresh Jadhav, Jean-Marie Preaud, Simonetta Viviani, F. Marc LaForce, Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial, Vaccine, 2012, 30, 45, 6456

    CrossRef

  15. 15
    Scott A. Halperin, Julie A. Bettinger, Brian Greenwood, Lee H. Harrison, Jane Jelfs, Shamez N. Ladhani, Peter McIntyre, Mary E. Ramsay, Marco A.P. Sáfadi, The changing and dynamic epidemiology of meningococcal disease, Vaccine, 2012, 30, B26

    CrossRef

  16. 16
    Sunil Karande, Update on Imminent Vaccines: Report of the APPA VU 2010: II, The Indian Journal of Pediatrics, 2011, 78, 8, 993

    CrossRef

  17. 17
    Thambu D Sudarsanam, Priscilla Rupali, Prathap Tharyan, Ooriapadickal Cherian Abraham, Kurien Thomas, Pre-admission antibiotics for suspected cases of meningococcal disease, The Cochrane Library,